Sodium arsenite inhibits proteoglycan synthesis by vascular endothelial cells in culture

Journal of Health Science

Volumn 51, Issue 4, 2005, Pages 461-468

  Fujiwara, Yasuyuki ^a   Nakase, Yusuke ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Arsenite; Atherosclerosis; Glycosaminoglycan; Proteoglycan; Vascular endothelial cell

Indexed keywords

ARSENIC TRIOXIDE; ARSENITE SODIUM; DERMATAN SULFATE; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; NONHUMAN; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM; VASCULAR LESION;

ANIMALIA; BOVINAE;

EID: 24744460059     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.51.461     Document Type: Article

References (45)

1. Ruoslahti, E. (1988) Structure and biology of proteoglycans. Annu. Rev. Cell Biol., 4, 229-255.
2. Saku, T. and Furthmayr, H. (1989) Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J. Biol. Chem., 264, 3514-3523.
3. Järveläinen, H. T., Kinsella, M. G., Wight, T. N. and Sandell, L. J. (1991) Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem., 266, 23274-23281.
4. Wight, T. N. (1989) Cell biology of arterial proteoglycans. Arteriosclerosis, 9, 1-20.
5. Camejo, G. (1982) The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv. Lipid Res., 19, 1-53.
6. Saxena, U. and Goldberg, I. J. (1994) Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr. Opin. Lipidol., 5, 316-322.
7. Berenson, G. S., Radhakrishnamurthy, B., Srinivasan, S. R., Vijayagopal, P., Dalferes, E. R., Jr. and Sharma, C. (1984) Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity-a role in atherogenesis. Exp. Mol. Pathol., 41, 267-287.
8. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell, 79, 1005-1013.
9. Hildebrand, A., Romaris, M., Rasmussen, L. M., Heinegard, D., Twardzik, D. R., Border, W. A. and Ruoslahti, E. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β. Biochem. J., 302, 527-534.
10. Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulators of growth factor activities. Cell, 64, 867-879.
11. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London), 362, 801-809.
12. Houtman, J. R. (1993) Prolonged low-level cadmium intake and atherosclerosis. Sci. Total Environ., 138, 31-36.
13. Revis, N. W., Zinsmeister, A. R. and Bull, R. (1981) Atherosclerosis and hypertension induced by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. U.S.A., 78, 6494-6498.
14. Kaji, T. (2004) Cell biology of heavy metal toxicity in vascular tissue. Yakugaku Zasshi, 124, 113-120.
15. Fujiwara, Y. and Kaji, T. (2000) Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sci., 46, 1-4.
16. Kaji, T., Ohkawara, S., Yamamoto, C., Sakamato, M. and Kozuka, H. (1994) Cadmium-induced alteration of glycosaminoglycans with an enhancement of heparin-like activity in cultured vascular endothelial cells. Toxicology, 94, 161-171.
17. Ohkawara, S., Yamamoto, C., Fujiwara, Y., Sakamoto, M. and Kaji, T. (1997) Cadmium induces the production of high molecular weight heparan sulfate proteoglycan molecules in cultured vascular endothelial cells. Environ. Toxicol. Pharmacol., 3, 187-194.
18. Fujiwara, Y., Tsumura, N., Yamamoto, C. and Kaji, T. (2002) Different effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extracellular matrix at low cell density. Toxicology, 170, 89-101.
19. Fujiwara, Y. (2004) Cell biological study on abnormal proteoglycan synthesis in vascular cells exposed to heavy metals. J. Health Sci., 50, 197-204.
20. Engel, R. R. and Smith, A. H. (1994) Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch. Environ. Health, 49, 418-427.
21. Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J. and Calderon, R. L. (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect., 107, 359-365.
22. Tseng, C. H., Chong, C. K., Chen, C. J., Lin, B. J. and Tai, T. Y. (1995) Abnormal peripheral microcirculation in seemingly normal subjects living in Blackfoot-disease-hyperendemic villages in Taiwan. Int. J. Microcirc., 15, 21-27.
23. Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H. and Wu, H. Y. (1988) Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of Blackfoot disease. Arteriosclerosis, 8, 452-460.
24. Chen, C. J., Chiou, H. Y., Chiang, M. H., Lin, L. J. and Tai, T. Y. (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol., 16, 504-510.
25. Tseng, C. H., Chong, C. K., Tseng, C. P., Hsueh, Y. M., Chiou, H. Y., Tseng, C. C. and Chen, C. J. (2003) Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett., 137, 15-21.
26. Wu, M. M., Kuo, T. L., Hwang, Y. H. and Chen, C. J. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol., 130, 1123-1132.
27. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C. and Waalkes, M. (1999) Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect., 107, 593-597.
28. Buchet, J. and Lison, D. (2000) Clues and uncertainties in the risk assessment of arsenic in drinking water. Food Chem. Toxicol., 38, S81-S85.
29. Simeonova, P. P. and Luster, M. I. (2004) Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol., 198, 444-449.
30. -/- mice. Environ. Health Perspect., 111, 1744-1748.
31. Bunderson, M., Brooks, D. M., Walker, D. L., Rosenfeld, M. E., Coffin, J. D. and Beall, H. D. (2004) Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol., 201, 32-39.
32. Wasteson, Å., Uthne, K. and Westermark, B. (1973) A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells. Biochem. J., 136, 1069-1074.
33. Kissane, J. M. and Robins, E. (1958) The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J. Biol. Chem., 233, 184-188.
34. Kinsella, M. G. and Wight, T. N. (1986) Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol., 102, 679-687.
35. 1, in cultured bovine aortic endothelial cells. J. Biol. Chem., 275, 1463-1470.
36. Jiang, S, J., Lin, T. M., Wu, H. L., Han, H. S. and Shi, G. Y. (2002) Decrease of fibrinolytic activity in human endothelial cells by arsenite. Thromb. Res., 105, 55-62.
37. Mertens, G., Cassiman, J. J., Van den Berghe, H., Vermylen, J. and David, G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J. Biol. Chem., 267, 20435-20443.
38. Whinna, H. C., Choi, H. U., Rosenberg, L. C. and Church, F. C. (1993) Interaction heparin cofactor II with biglycan and decorin. J. Biol. Chem., 268, 3920-3924.
39. Sato, Y. and Rifkin, D. B. (1988) Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107, 1199-1205.
40. Barchowsky, A., Dudek, E. J., Treadwell, M. D. and Wetterhahn, K. E. (1996) Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radic. Biol. Med., 21, 783-790.
41. Barchowsky, A., Roussel, R. R., Klei, L. R., James, P. E., Ganju, N., Smith, K. R. and Dudek, E. J. (1999) Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol., 159, 65-75.
42. Roboz, G. J., Dias, S., Lam, G., Lane, W. J., Soignet, S. L., Warrell, R. P., Jr. and Rafii, S. (2000) Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood, 96, 1525-1530.
43. Tseng, C. H., Chong, C. K., Chen, C. J. and Tai, T. Y. (1997) Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology, 48, 321-345.
44. Pi, J., Kumagai, Y., Sun, G., Yamauchi, H., Yoshida, T., Iso, H., Endo, A., Yu, L., Yuki, K., Miyauchi, T. and Simojo, N. (2000) Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med., 28, 1137-1142.
45. Engel, R. R., Hopenhayn-Rich, C., Receveur, O. and Smith, A. H., (1994) Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev., 16, 184-208.